Concurrent chemoradiotherapy using carboplatin/cetuximab regimen in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) not eligible for high-dose cisplatin (HD-DDP)

被引：0
|
作者：
Saigal, Kunal
Warsch, Sean
Mandalia, Amar
Samuels, Michael
Tolba, Khaled A.
Ikpeazu, Chukwuemeka
Kwon, Deukwoo
Santos, Edgardo S.
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16001
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [22] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [23] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [24] Preliminary analysis of ECOG 3303: Concurrent radiation (RT), cisplatin (DDP) and cetuximab (C) in unresectable, locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)
    Langer, C. J.
    Lee, J. W.
    Patel, U. A.
    Shin, D. M.
    Argiris, A. E.
    Quon, H.
    Ridge, J. A.
    Forastiere, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Efficacy and Safety of a Dexamethasone-Free Antiemetic Regimen for Nausea nd Emesis Prevention during Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC): A Phase 2 Trial
    Liu, Y.
    Yi, J.
    Zhang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S150 - S151
  • [26] Concurrent Weekly Cisplatin and Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
    Ahmed, Imtiaz
    Krishnamurthy, Sapna
    Bhise, Rohan
    Vinchurkar, Kumar
    Kalloli, Mahesh
    ORAL ONCOLOGY, 2021, 118
  • [27] Cisplatin versus Carboplatin in Radiochemotherapy for Patients with locally advanced Head and Neck Squamous Cell Carcinoma
    Nassif, S.
    Wichmann, J.
    Christiansen, H.
    Steinmann, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S129 - S129
  • [28] Accelerated fractionation and concurrent carboplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Hartley, A. G.
    Sanghera, P.
    Wong, D.
    Glaholm, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S380 - S380
  • [29] eVOLVE-HNSCC: A global phase 3 study of volrustomig as sequential therapy for unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) following definitive concurrent chemoradiotherapy (cCRT)
    Haddad, Robert I.
    Ruscica, Dario
    Visa, Alexandra
    Li, Xia
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Prognostic significance of epithelitis by concurrent cetuximab and radiotherapy (RT) for locally advanced head and neck squamous cell carcinoma (HNSCC) patients (Pts)
    Grau, J. J.
    Tagliapietra, A.
    Verger, E.
    Cabailero, M.
    Munoz, C.
    Alos, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345